Financhill
Sell
39

JANX Quote, Financials, Valuation and Earnings

Last price:
$28.82
Seasonality move :
-4.46%
Day range:
$24.92 - $27.07
52-week range:
$22.52 - $71.71
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
110.67x
P/B ratio:
1.55x
Volume:
1.6M
Avg. volume:
981.1K
1-year change:
-39.78%
Market cap:
$1.6B
Revenue:
$10.6M
EPS (TTM):
-$1.28

Earnings Data

Next earnings date for JANX
May 08
2025
Most recent earnings per share
-$0.36
Beat by $0.09
(Dec 31/2024)
Consensus Estimate
-$0.45
(Dec 31/2024)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

JANX Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
06/30/2025 Q2 $600K -- -- -$0.45 --
05/08/2025 Q1 $590.9K -- -- -$0.39 --
12/31/2024 Q4 $1.3M -- -$0.36 -$0.45 $0.09
11/06/2024 Q3 $1.6M $439K -$0.51 -$0.36 -$0.15
08/07/2024 Q2 $863.1K $8.9M -$0.11 -$0.29 $0.18
05/08/2024 Q1 $1M $1.3M -$0.30 -$0.33 $0.03
03/08/2024 Q4 $739.3K $2.5M -$0.24 -$0.39 $0.15
11/07/2023 Q3 -- -- -$0.25 -$0.43 $0.18
08/08/2023 Q2 -- -- -$0.42 -$0.51 $0.09
05/09/2023 Q1 -- -- -$0.42 -$0.47 $0.05
03/10/2023 Q4 -- -- -$0.39 -$0.50 $0.11
11/10/2022 Q3 -- -- -$0.40 -$0.53 $0.13
08/09/2022 Q2 -- -- -$0.41 -$0.39 -$0.02
05/10/2022 Q1 -- -- -$0.32 -- --
03/18/2022 Q4 -- -- -$0.33 -- --
11/09/2021 Q3 -- -- -$0.26 -- --
08/10/2021 Q2 -- -- -$0.62 -- --
03/31/2021 Q1 -- -- -$0.06 -- --
12/31/2020 Q4 -- -- -$0.13 -- --
09/30/2020 Q3 -- -- -$0.10 -- --
06/30/2020 Q2 -- -- -$0.20 -- --
03/31/2020 Q1 -- -- -$0.11 -- --

Janux Therapeutics Earnings Questions

  • How Much did Janux Therapeutics Generate in Revenue Last Quarter?

    Janux Therapeutics reported -- worth of top line sales in its most recent quarter.

  • Did Janux Therapeutics Beat Earnings Last Quarter?

    Janux Therapeutics announced earnings per share of -$0.36 which represents a beat of analyst forecast a -$0.45 per share.

  • Is Janux Therapeutics Profitable?

    Janux Therapeutics reported -- that represents -- per share over the last quarter.

  • What is the Analyst Consensus for Janux Therapeutics EPS Next Year?

    Janux Therapeutics's earnings are forecast to decrease from -$1.28 per share to -$1.30 per share next year representing a decrease of -59.72%.

  • When is Janux Therapeutics's Earnings Date?

    Janux Therapeutics's next earnings date is May 8, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

What Do Tesla Delivery Numbers Mean for Tesla Stock?
What Do Tesla Delivery Numbers Mean for Tesla Stock?

Tesla (NASDAQ:TSLA) released Q1 delivery numbers, showing a substantial slowdown…

Is Chewy a Growth Stock to Buy?
Is Chewy a Growth Stock to Buy?

It might be a surprise to learn that during the…

Is Realty Income the Best Dividend Stock to Buy Long-Term?
Is Realty Income the Best Dividend Stock to Buy Long-Term?

Realty Income (NYSE:O) is a longstanding real estate investment trust…

Stock Ideas

Sell
45
Is AAPL Stock a Buy?

Market Cap: $2.9T
P/E Ratio: 31x

Sell
46
Is MSFT Stock a Buy?

Market Cap: $2.8T
P/E Ratio: 32x

Sell
42
Is NVDA Stock a Buy?

Market Cap: $2.6T
P/E Ratio: 37x

Alerts

Sell
11
CRL alert for Apr 11

Charles River Laboratories International [CRL] is down 0.2% over the past day.

Buy
77
DPST alert for Apr 11

Direxion Daily Regional Banks Bull 3X Shares [DPST] is down 0.79% over the past day.

Sell
35
KMX alert for Apr 11

CarMax [KMX] is up 2.87% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock